¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"absorbed dose conversion factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
internal conversion
³»ºÎº¯È¯
positive conversion
¾ç¼ºÀüȯ
peripheral conversion
¸»ÃÊÀüȯ
acceptable daily dose
ÀÏÀÏÇã¿ë·®
average dose
1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
air dose
°ø±â¼±·®
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
booster dose
1. Ãß°¡¿ë·® 2. Ãß°¡Á¢Á¾·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
committed dose equivalent
¿¹Å¹¼±·®ÇØ´ç·®
committed effective dose
¿¹Å¹À¯È¿¼±·®
cumulative dose
1. ´©Àû¿ë·® 2. ´©Àû¼±·®
curative dose
1. Ä¡À¯¿ë·® 2. Ä¡À¯¼±·®
depth dose
½ÉºÎ¼±·®
depth dose curve
½ÉºÎ¼±·®°î¼±
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
dose-response relationship
¿ë·®¹ÝÀÀ°ü°è
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
coagulation V factor
Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
exclusion of confounding factor
±³¶õº¯¼ö¹èÁ¦
growth factor
¼ºÀåÀÎÀÚ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
digital scan conversion
µðÁöÅнºÄµº¯È¯
gene conversion
À¯ÀüÀÚº¯È¯
hysterical conversion
È÷½ºÅ׸®Àüȯ
internal conversion
³»ºÎº¯È¯
lysogenic conversion
¿ë¿øÀüȯ
phage conversion
ÆÄÁöÀüȯ, ÆÄÁö±³È¯
positive conversion
¾çÀü
direct conversion x-ray detector
Á÷Á¢Àüȯ¿¢½º¼±°ËÃâ±â, Á÷Á¢º¯È¯¿¢½º¼±°ËÃâ±â
egg negative conversion rate
Ãæ¶õÀ½ÀüÀ²
acceptable daily dose
ÀÏÀÏÇã¿ë·®
air dose
°ø±â¼±·®
average dose
Æò±Õ¿ë·®, Æò±Õ¼±·®
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
booster dose
Ãß°¡Á¢Á¾·®, Ãß°¡¿ë·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
F factor (fertility factor)
FÀÎÀÚ, ¼öÅÂÀÎÀÚ
ED 50=£¾effective dose 50%
50% À¯È¿·®, Áß°£À¯È¿·®.
ED 50=£¾effective dose 50%
50% À¯È¿·®.
ED 50=ÊÝeffective dose 50%
50% À¯È¿·®.
ED=ÊÝeffective dose
À¯È¿·®.
ID50 (50% infectious dose)
50% °¨¿°·®
LD = lethal dose
Ä¡»ç·®.
LD50 (50% lethal dose)
50% Ä¡»ç·®
LD= lethal dose
Ä¡»ç·®.
MED => minimum effective dose
ÃÖ¼ÒÈ«¹Ý·®
MED=> minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MED=£¾minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MTD=> maximum toderance dose
ÃÖ´ë³»¿ë·®.
MTD=£¾maximum tolerance dose
ÃÖ´ë³»¿ë·®.
MTD=ÊÝmaximum toderance dose
ÃÖ´ë³»¿ë·®.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cumulative dose ; cumulate dose
ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® , [¿¹¹æ] ÁýÀû¼±·®.
cumulative dose ; cumulate dose
ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® .[¿¹¹æ]ÁýÀû¼±·®.
dose rate ; dosage rate ; dose per unit time
¹æ»ç ÀÓº´,ÇÙÀÇ,¾à¸®¼±·®·ü, ¿ë·®.
optimal dose ; optimum dose
ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
optimal dose ; optimum dose
¹æ»ç [¾à¸®,ÇØºÎ,¿¹¹æ]ÃÖÀû·®, ÀûÁ¤·®(ËøËøËâ).
optimal dose ; optimum dose
ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
dose limiting factor
¼±·®ÇѵµÀÎÀÚ, ¼±·®Á¦ÇÑÀÎÀÚ
dose modifying factor
¼±·®¼ö½Ä°è¼ö
dose-reduction factor
¼±·®°¨¼Ò°è¼ö
time-dose factor
½Ã°£¼±·®ÀÎÀÚ
conversion
Àüȯ(ï®üµ).
conversion disorder
ÀüȯÀå¾Ö(ï®üµî¡äô)., Àüȯº´
conversion heat
Àüȯ¿(ï®üµæð).
conversion neurosis
Àüȯ½Å°æÁõ(ï®üµ ãêÌèñø)., Àüȯ½Å°æº´
conversion rate
ÀüȯÀ²(ï®üµëÒ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½